Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay

Journal of Clinical Laboratory Analysis

Volumn 11, Issue 5, 1997, Pages 258-266

  Kobayashi, Hiroyuki ^a   Takemura, Yuzuru ^a   Miyachi, Hayato ^b   Kawabata, Masaki ^a   Mori, Shigehisa ^c   Kawai, Yohko ^d   Furihata, Kenichi ^e   Sekiguchi, Susumu ^a   Watanabe, Kiyoaki ^d  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer chemotherapy; Drug resistance; Human leukemia cells; P glycoprotein

Indexed keywords

GLYCOPROTEIN P;

ACCURACY; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; COMPETITIVE INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PHENOTYPE; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BINDING, COMPETITIVE; BLOTTING, NORTHERN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; GENES, MDR; HUMANS; LEUKEMIA; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TUMOR CELLS, CULTURED;

EID: 0030854123     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1997)11:5<258::AID-JCLA4>3.0.CO;2-3     Document Type: Article

References (42)

1. Kartner N, Shales M, Riordan JR, Ling V: Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res 43:4413-4419, 1983.
2. Tsuruo T: Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 79:285-296, 1988.
3. Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83:4538-4542, 1986.
4. Ueda K, Cardarelli C, Gottesman MM, Pastan I: Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84:3004-3008, 1987.
5. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116-124, 1989.
6. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D: Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79:473-476, 1992.
7. Van der Heyden S, Gheuens E, DeBruijn E, Van Oosterom A, Maes R: P-glycoprotein: clinical significance and methods of analysis. Critical Rev in Clin Labo Sci 32:221-264, 1995.
8. de Kant E, Rochlitz CF, Herrmann R: Gene expression analysis by a competitive and differential PCR with antisense competitors. Biotechniques 17:934-942, 1994.
9. Kato S, Ideguchi H, Futata Y, Hamasaki N, Umemura T, Nishimura J: Analysis of mdr-1 gene expression in human leukemic cells by quantitative competitive PCR. Leukemia & Lymphoma 14:129-135, 1994.
10. Debuire B, Sol O, Lemoine A, May E: Nonisotopic competitive RT-PCR assay to measure MDR1 gene expression. Clin Chem 41:819-825, 1995.
11. Minowada J, Ohnuma T, Moore GE: Rosette-forming human lymphoid cell lines I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 49:891-895, 1972.
12. Arkin H, Ohnuma T, Kamen BA, Holland JF, Vallabhajosula S: Multidrug resistance in a human leukemic ceil line selected for resistance to trimetrexate. Cancer Res 49:6556-6561, 1989.
13. Li XK, Kobayashi H, Holland JF, Ohnuma T: Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell lines. Leukemia Res 17:483-490, 1993.
14. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples. Biotechniques 15:532-537, 1993.
15. Kobayashi H, Takemura Y, Ohnuma T: Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine: mechanism of inoculum effects. Cancer Chemother Pharmacol 31:6-10, 1992.
16. Hamada H, Tsuruo T: Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789, 1986.
17. Kobayashi H, Dorai T, Holland JF, Ohnuma T: Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Cancer Res 54:1271-1275, 1994.
18. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC: A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85:4486-4490, 1988.
19. Chomczynski P: One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem 201:134-139, 1992.
20. Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB: Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem 265:506-514, 1990.
21. Takeishi K, Kaneda S, Ayusawa D, Shimizu K, Gotoh O, Seno T: Nucleotide sequence of a functional cDNA for human thymidylate synthase. Nucleic Acids Res 13:2035-2043, 1985.
22. Shimazaki H, Kobayashi H, Takemura Y, Tamai S, Sekiguchi S: Simple, efficient, reliable, subcloning method of reverse transcription-polymerase chain reaction product into mammalian expression vectors. J Natl Def Med Coll 21:95-98, 1996.
23. Siebert PD, Larrick JW: Competitive PCR. Nature 359:557-558, 1992.
24. Bommhardt U, Cerottini J-C, MacDonald HR: Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function. Eur J Immunol 24:2974-2981, 1994.
25. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stern cells. Cell 66:85-94, 1991.
26. Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735-2739, 1992.
27. Klimecki WT, Futsher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451-2458, 1994.
28. + cases. Blood 86:2329-2342, 1995.
29. Murphy LD, Herzog CE, Rudick JB, Tito Fojo A, Bates SE: Use of the polymerase chain reaction in the quantitation of mdr1 gene expression. Biochemistry 29:10351-10356, 1990.
30. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wuner JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160-7164, 1990.
31. Miyachi H, Takemura Y, Yonekura S, Komatsuda M, Nagao T, Arimori S, Ando Y: MDR1 (multidrug resistance) gene expression in adult acute leukemia: correlation with blast phenotype. Int J Hematol 57:31-37, 1993.
32. Ostrowski LE, Krieg P, Finch J, Cress AE, Nagle R, Bowden GT: Expression of β-actin during progression of mouse skin rumors. Carcinogenesis 10:1439-1444, 1989.
33. Taylor JJ, Heasman PA: Control genes for reverse transcriptase/polymerase chain reaction (RT-PCR). Br J Haematol 86:444-445, 1994.
34. Garbay B, Boue-Grabot E, Garret M: Processed pseudogenes interfere with reverse transcriptase-polymerase chain reaction controls. Analytical Biochemistry 237:157-159, 1996.
35. Wei Q, Xu X, Cheng L, Legerski RJ, Ali-Osman F: Simultaneous amplification of four DNA repair genes and β-actin in human lymphocytes by multiplex reverse transcriptase-PCR. Cancer Res 55:5025-5029, 1995.
36. Henco K, Heibey M: Quantitative PCR: The determination of template copy number by temperature gradient gel electrophoresis (TGGE). Nucleic Acids Res 18:6733-6734, 1990.
37. Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ: Multifactorial resistance to adriamycin: relationships of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and-resistant P388 leukemia. Cancer Res 48:3595-3602, 1988.
38. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R: Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations. Cancer Res 56:3010-3020, 1996.
39. Nakayama H, Yokoi H, Fujita J: Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res 20:4939, 1992.
40. Katz ED, Dong MW: Rapid analysis and purification of polymerase chain reaction products by high-performance liquid chromatography. Biotechniques 8:546-555, 1990.
41. van Hille B, Lohri A, Reuter J, Herrman R: Nonradioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC. Clin Chem 41:1087-1093, 1995.
42. Warren W, Wheat T, Knudsen P: Rapid analysis and quantitation of PCR products by high-performance liquid chromatography. Biotechniques 11:250-255, 1991.